Patents by Inventor Richard A. Bergs
Richard A. Bergs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230126319Abstract: Uncultured amniotic cell and protein fraction products derived from amniotic fluid and methods of preparing and using those compositions are provided. According to the methods of the present invention, uncultured amniotic cell and protein products may be derived from a large sample of amniotic fluid to provide a higher concentration of tissue regeneration components. Described are methods for separating uncultured amniotic cells or protein fractions from other components of amniotic fluid and the resulting uncultured amniotic cell and protein products. Furthermore, the present invention includes methods for delivering the uncultured amniotic cell and protein products to the skin and eye, including before, during, or after a treatment procedure.Type: ApplicationFiled: December 14, 2022Publication date: April 27, 2023Applicant: StimLabs LLCInventors: John Daniel, Richard A. Berg, Sarah Griffiths
-
Publication number: 20230103744Abstract: Compositions comprising unseparated amnion/chorion derived from the placenta and methods of preparing and using those compositions are provided. Washing or preservation of placental tissue according to the methods of the disclosure may allow for one or more benefits such as more efficient removal of blood remnants, retention of wound healing and tissue regeneration components, better handling characteristics, increased absorption potential, or improved healing capacity. The present invention also includes methods of healing a wound of the skin, eye, nerve, tendon, or dura comprising applying the compositions of the invention to the wound.Type: ApplicationFiled: November 29, 2022Publication date: April 6, 2023Applicant: StimLabs LLCInventors: John Daniel, Sarah Griffiths, Richard Berg
-
Patent number: 11559553Abstract: Uncultured amniotic cell and protein fraction products derived from amniotic fluid and methods of preparing and using those compositions are provided. According to the methods of the present invention, uncultured amniotic cell and protein products may be derived from a large sample of amniotic fluid to provide a higher concentration of tissue regeneration components. Described are methods for separating uncultured amniotic cells or protein fractions from other components of amniotic fluid and the resulting uncultured amniotic cell and protein products. Furthermore, the present invention includes methods for delivering the uncultured amniotic cell and protein products to the skin and eye, including before, during, or after a treatment procedure.Type: GrantFiled: June 27, 2016Date of Patent: January 24, 2023Assignee: StimLabs LLCInventors: John Daniel, Richard A. Berg, Sarah Griffiths
-
Publication number: 20220331484Abstract: Compositions comprising unseparated amnion/chorion derived from the placenta and methods of preparing and using those compositions are provided. Washing or preservation of placental tissue according to the methods of the disclosure may allow for one or more benefits such as more efficient removal of blood remnants, retention of wound healing and tissue regeneration components, better handling characteristics, increased absorption potential, or improved healing capacity. The present invention also includes methods of healing a wound of the skin, eye, nerve, tendon, or dura comprising applying the compositions of the invention to the wound.Type: ApplicationFiled: July 6, 2022Publication date: October 20, 2022Applicant: StimLabs LLCInventors: John Daniel, Sarah Griffiths, Richard Berg
-
Patent number: 11413372Abstract: Compositions comprising unseparated amnion/chorion derived from the placenta and methods of preparing and using those compositions are provided. Washing or preservation of placental tissue according to the methods of the disclosure may allow for one or more benefits such as more efficient removal of blood remnants, retention of wound healing and tissue regeneration components, better handling characteristics, increased absorption potential, or improved healing capacity. The present invention also includes methods of healing a wound of the skin, eye, nerve, tendon, or dura comprising applying the compositions of the invention to the wound.Type: GrantFiled: September 16, 2016Date of Patent: August 16, 2022Assignee: StimLabs LLCInventors: John Daniel, Sarah Griffiths, Richard Berg
-
Publication number: 20220023502Abstract: Compositions comprising perforated, unseparated amnion/chorion; perforated, separated amnion; and perforated, separated chorion derived from the placenta and methods of preparing and using those compositions are provided. Perforation of placental tissue before or during processing may allow for one or more benefits such as more efficient removal of blood remnants, retention of wound healing and tissue regeneration components, better handling characteristics, or improved healing capacity. The present invention also includes methods of healing a wound of the skin, eye, nerve, tendon, or dura comprising applying the perforated compositions of the invention to the wound.Type: ApplicationFiled: August 5, 2021Publication date: January 27, 2022Applicant: StimLabs LLCInventors: John Daniel, Sarah Griffiths, Richard Berg
-
Patent number: 11116871Abstract: Compositions comprising perforated, unseparated amnion/chorion; perforated, separated amnion; and perforated, separated chorion derived from the placenta and methods of preparing and using those compositions are provided. Perforation of placental tissue before or during processing may allow for one or more benefits such as more efficient removal of blood remnants, retention of wound healing and tissue regeneration components, better handling characteristics, or improved healing capacity. The present invention also includes methods of healing a wound of the skin, eye, nerve, tendon, or dura comprising applying the perforated compositions of the invention to the wound.Type: GrantFiled: September 16, 2016Date of Patent: September 14, 2021Assignee: STIMLABS LLCInventors: John Daniel, Sarah Griffiths, Richard Berg
-
Patent number: 10490106Abstract: Provided herein are systems, methods, and apparatuses for simulating ailments that can be diagnosed by an abdominal palpation exam. Furthermore, provided herein are systems, methods, and apparatuses for analyzing an abdominal palpation exam. An abdominal simulator may include a surface layer, a sensor layer beneath the surface layer, a muscle layer beneath the sensor layer, a tensing layer beneath the muscle layer, an ailment module layer beneath the tensing layer, and a control portion. The abdominal simulator may simulate an ailment that can be diagnosed by an abdominal palpation exam. The abdominal simulator may also detect at least one abdominal palpation that is performed by a user on the abdominal simulator to diagnose the ailment that was simulated by the abdominal simulator. Moreover, the abdominal simulator may determine data for the at least one abdominal palpation that was detected.Type: GrantFiled: December 15, 2014Date of Patent: November 26, 2019Assignees: Board of Regents, The University of Texas System, ACDET LLCInventors: Richard A. Bergs, David G. Aldrich, Nicholas T. Papa, Jonathan E. Ruffin, David M. Huitt
-
Publication number: 20180311283Abstract: Uncultured amniotic cell and protein fraction products derived from amniotic fluid and methods of preparing and using those compositions are provided. According to the methods of the present invention, uncultured amniotic cell and protein products may be derived from a large sample of amniotic fluid to provide a higher concentration of tissue regeneration components. Described are methods for separating uncultured amniotic cells or protein fractions from other components of amniotic fluid and the resulting uncultured amniotic cell and protein products. Furthermore, the present invention includes methods for delivering the uncultured amniotic cell and protein products to the skin and eye, including before, during, or after a treatment procedure.Type: ApplicationFiled: June 27, 2016Publication date: November 1, 2018Applicant: StimLabs LLCInventors: John Daniel, Richard A. Berg, Sarah Griffiths
-
Publication number: 20180280572Abstract: Compositions comprising unseparated amnion/chorion derived from the placenta and methods of preparing and using those compositions are provided. Washing or preservation of placental tissue according to the methods of the disclosure may allow for one or more benefits such as more efficient removal of blood remnants, retention of wound healing and tissue regeneration components, better handling characteristics, increased absorption potential, or improved healing capacity. The present invention also includes methods of healing a wound of the skin, eye, nerve, tendon, or dura comprising applying the compositions of the invention to the wound.Type: ApplicationFiled: September 16, 2016Publication date: October 4, 2018Applicant: StimLabs LLCInventors: John Daniel, Sarah Griffiths, Richard Berg
-
Publication number: 20180250440Abstract: Compositions comprising perforated, unseparated amnion/chorion; perforated, separated amnion; and perforated, separated chorion derived from the placenta and methods of preparing and using those compositions are provided. Perforation of placental tissue before or during processing may allow for one or more benefits such as more efficient removal of blood remnants, retention of wound healing and tissue regeneration components, better handling characteristics, or improved healing capacity. The present invention also includes methods of healing a wound of the skin, eye, nerve, tendon, or dura comprising applying the perforated compositions of the invention to the wound.Type: ApplicationFiled: September 16, 2016Publication date: September 6, 2018Applicant: StimLabs LLCInventors: John Daniel, Sarah Griffiths, Richard Berg
-
Patent number: 9682167Abstract: Compositions and method of manufacturing carboxypolysaccharides (CPS) including carboxymethyl cellulose (CMC) and polyethylene glycols (PEGs) are provided where the PEG is a PEG-epoxide covalently linked to the CPS. In certain embodiments, the PEG attaches to only one CPS, forming a decorated CPS. In other embodiments, the functional groups of a bi-functional PEG molecule (PEG diglycidyl ether) are attached to different CPSs, thereby forming a covalently cross-linked composition. Such compositions can be used as space-filling materials, load-bearing materials, anti-adhesion compositions, drug delivery vehicles, and lubricants of tissues and medical instruments.Type: GrantFiled: June 22, 2016Date of Patent: June 20, 2017Assignee: FZIOMED, INC.Inventors: Samuel J. Falcone, Richard A. Berg
-
Patent number: 9627120Abstract: Apparatuses and systems for enabling electrical communication with a device positionable within a body cavity of a patient. Apparatuses and systems for magnetically positioning a device within a body cavity of a patient. Medical devices. Methods of use.Type: GrantFiled: May 19, 2010Date of Patent: April 18, 2017Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEMInventors: Daniel J. Scott, Raul Fernandez, Richard A. Bergs, Jeffrey A. Cadeddu
-
Publication number: 20160314718Abstract: Provided herein are systems, methods, and apparatuses for simulating ailments that can be diagnosed by an abdominal palpation exam. Furthermore, provided herein are systems, methods, and apparatuses for analyzing an abdominal palpation exam. An abdominal simulator may include a surface layer, a sensor layer beneath the surface layer, a muscle layer beneath the sensor layer, a tensing layer beneath the muscle layer, an ailment module layer beneath the tensing layer, and a control portion. The abdominal simulator may simulate an ailment that can be diagnosed by an abdominal palpation exam. The abdominal simulator may also detect at least one abdominal palpation that is performed by a user on the abdominal simulator to diagnose the ailment that was simulated by the abdominal simulator. Moreover, the abdominal simulator may determine data for the at least one abdominal palpation that was detected.Type: ApplicationFiled: December 15, 2014Publication date: October 27, 2016Applicants: Board of Regents, The University of Texas System, ACDET LLCInventors: Richard A. Bergs, David G. Aldrich, Nicholas T. Papa, Jonathan E. Ruffin, David M. Huitt
-
Publication number: 20160303280Abstract: Compositions and method of manufacturing carboxypolysaccharides (CPS) including carboxymethyl cellulose (CMC) and polyethylene glycols (PEGs) are provided where the PEG is a PEG-epoxide covalently linked to the CPS. In certain embodiments, the PEG attaches to only one CPS, forming a decorated CPS. In other embodiments, the functional groups of a bi-functional PEG molecule (PEG diglycidyl ether) are attached to different CPSs, thereby forming a covalently cross-linked composition. Such compositions can be used as space-filling materials, load-bearing materials, anti-adhesion compositions, drug delivery vehicles, and lubricants of tissues and medical instruments.Type: ApplicationFiled: June 22, 2016Publication date: October 20, 2016Applicant: Fziomed, Inc.Inventors: Samuel J. Falcone, Richard A. Berg
-
Patent number: 9381271Abstract: Uses of compositions comprising carboxypolysaccharides (CPS) including carboxymethyl cellulose (CMC) and polyethylene glycols (PEGs) are provided where the PEG is a PEG-epoxide covalently linked to the CPS in the presence of NH4OH. In certain embodiments, the PEG attaches to only one CPS, forming a decorated CPS. In other embodiments, bi-functional PEG molecules are attached to adjacent CPSs, thereby forming a covalently cross-linked composition. Such compositions can be used as space-filling materials, load-bearing materials, anti-adhesion compositions, drug delivery vehicles, and lubricants of tissues and medical instruments.Type: GrantFiled: October 20, 2015Date of Patent: July 5, 2016Assignee: FZIOMED, INCInventors: Samuel J. Falcone, Richard A. Berg
-
Patent number: 9345809Abstract: Compositions comprising carboxypolysaccharides (CPS) including carboxymethyl cellulose (CMC) and polyethylene glycols (PEGs) are provided where the PEG is a PEG-epoxide covalently linked to the CPS via an addition reaction. In certain embodiments, the PEG attaches to only one CPS, forming a decorated CPS. In other embodiments, bi-functional PEG molecules are attached to adjacent CPSs, thereby forming a covalently cross-linked composition. In certain of these embodiments, a PEG is linked to the CPS by way of an ether linkage, and in other embodiments, a PEG is linked to the CPS by way of an ester linkage, and in still further embodiments, PEG molecule(s) can be attached to CPS molecule(s) by way of both ether and ester linkages. Additional embodiments include PEG/CMC compositions where the PEG is a multi-branch PEG and/or a multi-arm PEG.Type: GrantFiled: November 28, 2007Date of Patent: May 24, 2016Assignee: FZIOMED, Inc.Inventors: Samuel J. Falcone, Richard A. Berg
-
Publication number: 20160120613Abstract: Medical devices having a platform and an arm movable between a collapsed position and an expanded position. In some embodiments, the platform comprises at least one of a magnetically-attractive material and a material capable of being magnetically-charged. Methods of use.Type: ApplicationFiled: June 2, 2015Publication date: May 5, 2016Inventors: Jeffrey A. CADEDDU, Daniel J. SCOTT, Raul FERNANDEZ, Richard A. BERGS
-
Publication number: 20160038634Abstract: Uses of compositions comprising carboxypolysaccharides (CPS) including carboxymethyl cellulose (CMC) and polyethylene glycols (PEGs) are provided where the PEG is a PEG-epoxide covalently linked to the CPS in the presence of NH4OH. In certain embodiments, the PEG attaches to only one CPS, forming a decorated CPS. In other embodiments, bi-functional PEG molecules are attached to adjacent CPSs, thereby forming a covalently cross-linked composition. Such compositions can be used as space-filling materials, load-bearing materials, anti-adhesion compositions, drug delivery vehicles, and lubricants of tissues and medical instruments.Type: ApplicationFiled: October 20, 2015Publication date: February 11, 2016Inventors: Samuel J. Falcone, Richard A. Berg
-
Patent number: 9161987Abstract: Compositions comprising carboxypolysaccharides (CPS) including carboxymethyl cellulose (CMC) and polyethylene glycols (PEGs) are provided where the PEG is a PEG-epoxide covalently linked to the CPS. In certain embodiments, the PEG attaches to only one CPS, forming a decorated CPS. In other embodiments, bi-functional PEG molecules are attached to adjacent CPSs, thereby forming a covalently cross-linked composition. Additional embodiments include PEG/CMC compositions where the PEG is a multi-branch PEG and/or a multi-arm PEG. PEG/CMC compositions can be made with desired viscoelastic properties, and such compositions can be used as space-filling materials, load-bearing materials, anti-adhesion compositions, drug delivery vehicles or lubrication of tissues and medical instruments.Type: GrantFiled: June 24, 2014Date of Patent: October 20, 2015Assignee: FzioMed, Inc.Inventors: Samuel J. Falcone, Richard A. Berg